Microwave-assisted synthesis and dual in silico–in vitro profiling of vanillin azo-Schiff base hybrids for antimicrobial potential
Abstract
Abstract Researchers have demonstrated substantial interest in bioactive compounds derived from natural resources, such as vanillin, owing to their significant potential in drug development. Here, we report the efficient synthesis of hybrid azo-Schiff bases derived from vanillin 2(a–h) using vanillin azo 1(a–h) as natural product-based precursors, achieved via microwave irradiation to yield significant amounts (67–83%, 6 min) compared to conventional heating (38–53%, 36 h). Compounds 2(a–h) exhibited enhanced antibacterial activity against S. aureus (inhibition zones of 9–11 mm) compared to 1(a–h) (7–9 mm) and the parent vanillin, which showed no inhibition. Similarly, 2(a–h) demonstrated superior activity against E. coli (8–11 mm) relative to 1(a–h) (7–9 mm) and vanillin (no inhibition). Compound 2b exhibited the most potent antibacterial activity among the synthesised compounds, with inhibition zones of 11.03 ± 0.12 mm against E . coli and 11.20 ± 0.10 mm against S. aureus , comparable to the standard antibiotic ampicillin (11–12 mm). Compound 2b also revealed a strong binding affinity of − 7.3 kcal/mol in molecular docking analysis, alongside an energy gap of 3.45 eV as determined by DFT calculations using Gaussian 09, indicating favourable electronic properties for antimicrobial activity. The ADMET studies supported natural product-based hybrids derived from vanillin as suitable drug candidates. This research significantly advances drug design by presenting potent in…
How strong is the evidence?
Evidence Hub reads this as a simulation / modelling, done in cell cultures (in vitro) and computer models (in silico), not in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Synthesis, In Vitro and In Silico Molecular Docking Studies of Novel Phthalimide–Pyrimidine Hybrid Analogues to Thalidomide as Potent Antitubercular Agents
- Exploring the inhibitory performance of expired moxifloxacin and norfloxacin on copper corrosion in saline environment
- Molecular investigation of antimicrobial peptides against Helicobacter pylori proteins using a peptide-protein docking approach
- Screening of novel narrow-spectrum benzofuroxan derivatives for the treatment of multidrug-resistant tuberculosis through in silico, in vitro, and in vivo approaches
- Synthesis, Characterization, Anticancer, Antioxidant, and In Silico Evaluation of Semicarbazides and Thiosemicarbazides
- Fast and accurate prediction of drug induced proarrhythmic risk with sex specific cardiac emulators
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.